simendan has been researched along with propranolol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Sun, S; Tang, W; Wang, J; Weil, MH | 1 |
Kiviniemi, V; Kurola, J; Leppikangas, H; Lindgren, L; Ruokonen, E; Rutanen, J | 1 |
Dexeus, D; Hoffman, RS; Lugassy, DM; Nelson, LS; Stefan, A | 1 |
Graudins, A; Kalam, Y | 1 |
Abella, LMR; Gergs, U; Hoffmann, R; Hofmann, B; Neumann, J | 1 |
5 other study(ies) available for simendan and propranolol
Article | Year |
---|---|
Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiopulmonary Resuscitation; Cardiotonic Agents; Drug Therapy, Combination; Heart Arrest; Heart Rate; Hydrazones; Male; Propranolol; Pyridazines; Simendan; Swine | 2005 |
Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Overdose; Heart Failure; Hemodynamics; Hydrazones; Propranolol; Pyridazines; Random Allocation; Simendan; Survival Analysis; Swine | 2009 |
In response to Leppikangas H, et al, Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Heart Failure; Hemodynamics; Hydrazones; Propranolol; Pyridazines; Simendan; Swine | 2010 |
Levosimendan does not improve cardiac output or blood pressure in a rodent model of propranolol toxicity when administered using various dosing regimens.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Hydrazones; Male; Propranolol; Pyridazines; Rats; Rats, Wistar; Simendan | 2012 |
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
Topics: Animals; Atrial Fibrillation; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Mice; Myocardial Contraction; Phosphorylation; Propranolol; Rolipram; Simendan | 2023 |